ORANGE, CA--(Marketwired - Feb 3, 2014) - LiveWire Ergogenics, Inc. (OTCQB: LVVV) is pleased to announce the formation of a new division, LiveWire Herbaceuticals .

LiveWire's proprietary method adds a precise amount of THC and CBD to a flavored matrix resulting in a chew that has little or no aftertaste. LiveWire then uses an independent laboratory to verify the dosage. This product will be manufactured and distributed through dispensaries in states where it is legal.

LiveWire Herbaceuticals was formed to solve the most pressing issue in the legal medical marijuana industry which is dose and consistency control.

"The initial response to this technology has been overwhelming. We have our first order, and subject to legal approval, we should be in production by the end of the month. We believe that medical marijuana provides significant health benefits to consumers, and as this is adopted nationwide, we want to give consumers the ability to responsibly manage their dose. To provide precision in this product is an important key to success," said Bill Hodson , CEO of LiveWire Ergogenics, Inc.

For more information about LiveWire Ergogenics, Inc., or to find a LiveWire Territory Manager near you, please visit www.livewireenergy.com .